Jie Li, Ph.D.

China General Manager

As the China General Manager, Jie (Jack) Li leads operations that align with Caidya’s global strategy to drive sustainable growth in the Chinese market. He is instrumental in utilizing Caidya’s distinct global presence – especially in China – to establish effective multi regional clinical trial (MRCT) processes that set Caidya apart. Jack works closely with the Caidya Executive Leadership Team to ensure that all initiatives in China are aligned with the company’s global mission.

Jack brings a wealth of expertise to his role with over 20 years of management experience in global biopharmaceutical companies and CROs, including GlaxoSmithKline, AstraZeneca, Pfizer, and Parexel.

He holds a Doctorate in Biostatistics and a Master’s degree in Pharmacology from Fudan University and gets his Bachelor’s degree in Medical Informatics from Jilin University.

Global reach, local knowledge

Speak to one of our experts

Access the right people when and where you need them with personalized clinical services tailored to you and your trial.

Contact Us
Leading a new way

The latest from Caidya

Explore our news and updates as we deliver a superior customer experience.

03/13/2025

Caidya Strengthens Therapeutic Leadership: Names Adam Callahan Head of Oncology and Hematology

RALEIGH, N.C.; Mar. 13, 2025 – Caidya, a leading global,...

01/28/2025

Caidya Names Brandon Pallott as CCO to Drive Innovative Commercial Initiatives and Market Expansion

RALEIGH, N.C.; Jan. 28, 2025 – Caidya, a leading global,...

01/13/2025

Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders

RALEIGH, N.C.; Jan. 13, 2025 – Caidya, a leading global...
Skip to toolbar